These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 6627288)
61. Pharmacokinetics and pharmacodynamics of transdermally administered clonidine. Arndts D; Arndts K Eur J Clin Pharmacol; 1984; 26(1):79-85. PubMed ID: 6714294 [TBL] [Abstract][Full Text] [Related]
62. Rebound hypertension during initiation of transdermal clonidine. Stewart M; Burris JF Drug Intell Clin Pharm; 1988; 22(7-8):573-4. PubMed ID: 3416742 [TBL] [Abstract][Full Text] [Related]
64. The USA experience with the clonidine transdermal therapeutic system. Burris JF Clin Auton Res; 1993 Dec; 3(6):391-6. PubMed ID: 8193527 [TBL] [Abstract][Full Text] [Related]
65. Oral clonidine loading in hypertensive urgencies. Anderson RJ; Hart GR; Crumpler CP; Reed WG; Matthews CA JAMA; 1981 Aug; 246(8):848-50. PubMed ID: 7253160 [TBL] [Abstract][Full Text] [Related]
67. Comparison between osmotic mini-pumps and controlled release pellets in chronic clonidine administration in the spontaneously hypertensive rat. Hess RW; Hardman SL; Shirachi DY; Taubert KA Proc West Pharmacol Soc; 1985; 28():97-101. PubMed ID: 4070269 [No Abstract] [Full Text] [Related]
68. Use of oral clonidine for rapid titration of blood pressure in severe hypertension. Spitalewitz S; Porush JG; Oguagha C Chest; 1983 Feb; 83(2 Suppl):404-7. PubMed ID: 6822138 [TBL] [Abstract][Full Text] [Related]
70. Pharmacokinetics and antihypertensive effects of low dose clonidine during chronic therapy. Anavekar SN; Howes LG; Jarrott B; Syrjanen M; Conway EL; Louis WJ J Clin Pharmacol; 1989 Apr; 29(4):321-6. PubMed ID: 2723120 [TBL] [Abstract][Full Text] [Related]
71. Patient acceptance of transdermal clonidine. A retrospective review of 25 patients. Chen SW; Vidt DG Cleve Clin J Med; 1989; 56(1):21-6. PubMed ID: 2731324 [TBL] [Abstract][Full Text] [Related]
72. Pharmacokinetics and pharmacodynamics of a new transdermal clonidine, M-5041T, in healthy subjects. Fujimura A; Ebihara A; Shiga T; Kumagai Y; Ohashi K; Nakashima H; Kotegawa T J Clin Pharmacol; 1993 Dec; 33(12):1192-200. PubMed ID: 8126254 [TBL] [Abstract][Full Text] [Related]
73. Rebound hypertension after discontinuation of transdermal clonidine therapy. Metz S; Klein C; Morton N Am J Med; 1987 Jan; 82(1):17-9. PubMed ID: 3026180 [TBL] [Abstract][Full Text] [Related]
74. Transdermal clonidine for hypertension. Med Lett Drugs Ther; 1985 Oct; 27(700):95-6. PubMed ID: 4058369 [No Abstract] [Full Text] [Related]
75. Long-term (5 year) experience with transdermal clonidine in the treatment of mild to moderate hypertension. Breidthardt J; Schumacher H; Mehlburger L Clin Auton Res; 1993 Dec; 3(6):385-90. PubMed ID: 8193526 [TBL] [Abstract][Full Text] [Related]
76. Utility of a transdermal delivery system for antihypertensive therapy. Part 1. Sclar DA; Skaer TL; Chin A; Okamoto MP; Gill MA Am J Med; 1991 Jul; 91(1A):50S-56S. PubMed ID: 1907801 [TBL] [Abstract][Full Text] [Related]
77. Oral substitution in patients sensitized by transdermal clonidine treatment. Maibach HI Contact Dermatitis; 1987 Jan; 16(1):1-8. PubMed ID: 3816202 [TBL] [Abstract][Full Text] [Related]
78. Transdermal clonidine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Langley MS; Heel RC Drugs; 1988 Feb; 35(2):123-42. PubMed ID: 3281820 [TBL] [Abstract][Full Text] [Related]
79. Plasma Concentrations Following Application of Whole versus Cut Transdermal Clonidine Patches To Critically Ill Children. Zuppa AF; Tejani SM; Cullen EJ; Nadkarni VM J Pediatr Pharmacol Ther; 2004 Jan; 9(1):43-8. PubMed ID: 23118690 [TBL] [Abstract][Full Text] [Related]
80. [Characteristics of the course of arterial hypertension during long-term treatment with clonidine]. Moiseev VS; Ivleva AIa; Kobalava ZhD; Krasnobaeva GM Klin Med (Mosk); 1987 May; 65(5):47-51. PubMed ID: 3613481 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]